Woodline Partners’s Acumen Pharmaceuticals ABOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-426,172
| Closed | -$1.73M | – | 616 |
|
|
2023
Q1 | $1.73M | Hold |
426,172
| – | – | 0.02% | 431 |
|
|
2022
Q4 | $2.3M | Sell |
426,172
-5,986
| -1% | -$32.3K | 0.03% | 457 |
|
|
2022
Q3 | $4.34M | Buy |
432,158
+5,988
| +1% | +$60.1K | 0.06% | 327 |
|
|
2022
Q2 | $2M | Sell |
426,170
-75,066
| -15% | -$353K | 0.03% | 421 |
|
|
2022
Q1 | $1.96M | Buy |
501,236
+20,555
| +4% | +$80.4K | 0.03% | 384 |
|
|
2021
Q4 | $3.25M | Buy |
480,681
+11,887
| +3% | +$80.3K | 0.05% | 345 |
|
|
2021
Q3 | $6.97M | Buy |
+468,794
| New | +$6.97M | 0.11% | 211 |
|